Vice President of Commercial - U.S. Generics, Biosimilars & 505(b)(2)

Qualification and Experience

• Bachelor’s degree in Life Sciences or Business; MBA or equivalent preferred.
• 12+ years of progressive commercial experience in generics, biosimilars, and/or 505(b)(2) pharmaceuticals.
• Deep understanding of the U.S. payer and provider landscape.
• Ability to navigate regulatory nuances specific to generics and hybrid pathways. 
• Executive presence and a history of leading high-performing commercial teams. 

Preferred Attributes:

• Experience with digital marketing and data-driven decision-making. 
• Familiarity with 340B, 505B2, GPOs, and institutional customer segments. 
• Ability to navigate ambiguity and drive results in a competitive market.
• Demonstrated success in launching and optimizing performance for complex assets.

The anticipated annual base salary range for this position in New Jersey is $300,000 to $3500,000 base, plus a discretionary performance bonus (based upon eligibility). The final salary offered to a successful candidate may vary and will be dependent on several factors that may include but are not limited to: the type and length of experience within the job, the type and length of experience within the industry, skillset, education, business needs, etc. Lupin is a multi-state employer, and this salary range may not reflect positions that work in other states

Vice President of Commercial, Biosimilars

As Vice President of Commercial - U.S Generics, Biosimilars & 505(b)(2), you’ll lead the strategic development, launch, and growth of Lupin’s U.S. generics portfolio with a specialized focus on biosimilars and 505(b)(2) assets. This executive will drive market expansion, ensure profitable product positioning, and build commercial excellence across the organization. The VP/SVP will architect go-to-market strategies that enhance profitability, deepen market penetration, and position Lupin as a category leader. This role demands a forward-thinking enterprise builder who can translate deep market insight into cross-functional momentum.

Key Responsibilities:

• Strategic Leadership:
• Own and execute commercial strategies for U.S. generics, biosimilars, and 505(b)(2) assets, ensuring alignment with overall business objectives.
• Guide lifecycle management, pricing, and go-to-market planning for both pipeline and approved 505(b)(2)and generics products.
• Lead business development assessments for potential licensing, partnerships, and portfolio acquisitions within the 505(b)(2) and generics space.
• Collaboration & Alignment:
• Partner with Regulatory, R&D, Manufacturing, and Supply Chain teams to ensure commercial alignment and seamless execution of strategies for 505(b)(2) and generics products.
• Build strong relationships with wholesale distributors, pharmacy networks, GPOs, and payers to enhance market access and product uptake
• Market Intelligence & Competitive Analysis
• Monitor competitive intelligence, market trends, and reimbursement dynamics to inform strategic decisions and maintain a competitive edge in the 505(b)(2) and generics market.
• Oversee forecasting and budgeting processes for key therapeutic assets within the 505(b)(2) and generics portfolio.

Team Development & Leadership:

• Champion team development, culture building, and cross-functional collaboration to foster a high-performing and innovative team focused on 505(b)(2) and generics products.

Competencies